Connect Biopharma Holdings (CNTB) Tax Provisions (2024 - 2026)
Connect Biopharma Holdings (CNTB) posted quarterly Tax Provisions of $48000.0 for Q1 2026, down 11.11% year-on-year from $54000.0 in Q1 2025, and up 77.78% on a QoQ basis from $27000.0 in Q4 2025.
Connect Biopharma Holdings (CNTB) Tax Provisions (2024 - 2026) Analysis & Trends
Connect Biopharma Holdings (CNTB) has reported Tax Provisions for 3 consecutive years, with $48000.0 the latest figure, recorded in Q1 2026.
- Quarterly Tax Provisions fell 11.11% year-over-year to $48000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $191000.0 (down 22.67% YoY) and the FY2025 annual result came in at $197000.0, down 11.66% from the prior year.
- Tax Provisions climbed to $48000.0 in Q1 2026 per CNTB's latest filing, from $27000.0 in the prior quarter.
- Over the last five years, Tax Provisions for CNTB reached as high as $106000.0 in Q4 2024 and fell as low as $27000.0 in Q4 2025.
- A 3-year average of $52000.0 and a median of $54000.0 in 2025 frame the typical range for Tax Provisions.
- The largest YoY upside for Tax Provisions was 83.33% in 2025 against a maximum downside of 74.53% in 2025.
- Year by year, Tax Provisions stood at $106000.0 in 2024, then tumbled by 74.53% to $27000.0 in 2025, then jumped by 77.78% to $48000.0 in 2026.
- According to Business Quant data, Tax Provisions over the past three periods registered $48000.0, $27000.0, and $61000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,741.39 Bn | 66,741.11 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,935.05 Bn | 1,934.98 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 468.98 Bn | 464.19 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 123.24 Bn | 115.99 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 70.45 Bn | 61.70 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 63.04 Bn | 63.04 Bn | - | - |
| 8 | Argenx Se | 55.79 Bn | 50.60 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Alnylam Pharmaceuticals | 37.79 Bn | 34.78 Bn | 959.66 Mn | 15.66 Mn |
| 10 | Connect Biopharma Holdings | 121.01 Mn | 121.01 Mn | - | 48,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48,000.00 |
| Dec 31, 2025 | 27,000.00 |
| Sep 30, 2025 | 61,000.00 |
| Jun 30, 2025 | 55,000.00 |
| Mar 31, 2025 | 54,000.00 |
| Dec 31, 2024 | 106,000.00 |
| Sep 30, 2024 | 57,000.00 |
| Jun 30, 2024 | 30,000.00 |
| Mar 31, 2024 | 30,000.00 |